Page 151 – Vaccine development: a challenging enterprise

Professor Stephen C Inglis


  1. Waye A, Jacobs P, Schryvers AB. Vaccine development costs: a review. Exp Rev Vaccines 2013;12:1495–1501.
  2. Hall AJ. The United Kingdom Joint Committee of Vaccination and Immunisation. Vaccine 2010;A54–A57.
  3. Reed SG. Vaccine adjuvants. Exp Rev Vaccines 2013;12:705–706.
  4. Department of Health and Social Care. Open consultation: cost effectiveness methodology for vaccination programmes. Published 26 February 2018. Available at:
  5. The UK Vaccine R&D Network. Vaccine Development Process Map. Available at: